Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA

被引：0
|
作者：
Dmitry Evseev
Irina Kalinina
Elena Raykina
Daria Osipova
Zalina Abashidze
Anna Ignatova
Anna Mitrofanova
Alexey Maschan
Galina Novichkova
Michael Maschan
机构：
[1] Dmitry Rogachev National Medical Research Center of Pediatric Hematology,
[2] Oncology and Immunology,undefined
来源：
International Journal of Hematology | 2021年 / 114卷
关键词：
Histiocytosis; Langerhans cell histiocytosis; Molecular biology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：725 / 734
页数：9
相关论文
共 15 条
  • [11] It was not possible to detect BRAF V600E mutation in circulating cell-free DNA from patients with ameloblastoma: A diagnostic accuracy study
    Martins-de-Barros, Allan Vinicius
    da Costa Araujo, Fabio Andrey
    Barros, Ana Maria Ipolito
    dos Santos, Elenisa Glaucia Ferreira
    Barbosa Neto, Adauto Gomes
    da Silva, Helker Albuquerque Macedo
    de Lima, Elker Lene Santos
    Muniz, Maria Tereza Cartaxo
    Neves, Riedel Frota Sa Nogueira
    de Hollanda Valente, Romulo Oliveira
    Silva, Emanuel Dias
    de Vasconcelos Carvalho, Marianne
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2024, 53 (04) : 258 - 265
  • [12] Detection of BRAF V600E mutation in radiological Langerhans cell histiocytosis-associated neurodegenerative disease using droplet digital PCR analysis
    Shimizu, Soichiro
    Sakamoto, Kenichi
    Kudo, Ko
    Morimoto, Akira
    Shioda, Yoko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (01) : 119 - 124
  • [13] Detection of BRAF V600E mutation in radiological Langerhans cell histiocytosis-associated neurodegenerative disease using droplet digital PCR analysis
    Soichiro Shimizu
    Kenichi Sakamoto
    Ko Kudo
    Akira Morimoto
    Yoko Shioda
    International Journal of Hematology, 2023, 118 : 119 - 124
  • [14] The Interim Results of a Multicenter study of Safety and Efficacy of Vemurafenib and Cytarbine plus Cladribine Therapy in high-risk Pediatric Langerhans cell Histiocytosis with Braf V600E Mutation
    Evseev, Dmitry
    Osipova, Daria
    Kalinina, Irina
    Raykina, Elena
    Popov, Alexander
    Kotskaya, Natalia
    Chernyak, Ekaterina
    Burtsev, Evgeny
    Bronin, Gleb
    Tayshikhina, Irina
    Purbueva, Bazarma
    Fink, Olesya
    Pristanskova, Ekaterina
    Novitchkova, Galina
    Maschan, Alexey
    Maschan, Michael
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S6 - S6
  • [15] Detectable BRAF-V600E mutation in circulating peripheral blood of patients with Langerhans cell histiocytosis correlates with risk organ involvement and residual disease
    Simko, Stephen J.
    Berres, Marie-Luise
    Lim, Karen Phaik-Har
    Peters, Tricia
    Price, Jeremy
    Lupo, Philip J.
    Hicks, M. John
    Shih, Albert
    Heym, Kenneth
    McClain, Kenneth L.
    Merad, Miriam
    Sarabia, Stephen
    Lopez-Terrada, Dolores
    Allen, Carl E.
    CANCER RESEARCH, 2014, 74 (20)
12